Skip to main content
Equibles

MORGAN STANLEY

Position in SMMT — Summit Therapeutics Inc.

CIK 895421 NEW YORK, NY
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,126,775
-$10,168,426 QoQ
Shares Held
1,450,019
-12.2% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 242 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SMMT ranks #95 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in SMMT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,126,775 1,450,019
2026-03-31 $31,295,201 1,650,591
2025-12-31 $16,205,864 926,579
2025-09-30 $39,808,264 1,926,828
2025-06-30 $13,661,778 642,001
2025-03-31 $9,223,047 478,126
2024-12-31 $10,010,865 560,990
2024-09-30 $12,642,824 577,298
2024-06-30 $2,629,510 337,117
2024-03-31 $2,867,116 692,541
2023-12-31 $1,838,147 704,272
2023-09-30 $1,038,476 555,336
2023-06-30 $1,485,883 591,986
2023-03-31 $1,347,098 769,771
2022-12-31 $930,482 218,937
2022-09-30 $418,090 351,337
2022-06-30 $209,193 209,193
2022-03-31 $802,567 327,579
2021-12-31 $963,513 358,184
2021-09-30 $1,392,507 277,946
2021-06-30 $1,622,824 217,537
2021-03-31 $1,263,130 215,184
2020-12-31 $1,194,302 254,107
2020-09-30 $722,575 210,051